Abstract: . . .  meta-analysis of randomised controlled trials. Lancet 2000; 356 : 19491954. 20 Brown MJ et al . Morbidity and mortality in patients randomised to double-blind treatment with a long- acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356 : 366372. ALLHAT DG Beevers et al 372 Journal of Human Hypertension  . . .
. . .  Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157 : 24132446. 19 Pahor M et al . Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet 2000; 356 : 19491954. 20 Brown MJ et al . Morbidity and mortality in patients randomised to double-blind treatment with a long- . . .
. . .  antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet 2000; 356 : 19491954. 20 Brown MJ et al . Morbidity and mortality in patients randomised to double-blind treatment with a long- acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356 : 366372.  . . .
. . .  2002; 288 : 29983007. 4 The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Group. Major cardiovascular events in hypertensive patients randomized to dox- azosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA 2000; 283 : 19671975. 5 Klungel OH et al . Antihypertensive drug therapies and the risk of ischemic stroke. Arch Intern . . .
. . .  Brown MJ et al . Morbidity and mortality in patients randomised to double-blind treatment with a long- acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356 : 366372. ALLHAT DG Beevers et al 372 Journal of Human Hypertension  . . .
. . .  enalapril 20 mg: the LIVE study. J Hypertens 2000; 18 : 14651475. 18 The Joint National Committee on Prevention, Detec- tion, Evaluation, and Treatment Of High Blood Pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157 : 24132446. 19 Pahor M et al . Health outcomes associated with calcium antagonists compared with other first-line antihypertensive . . .
--3000,6,250,3329,36716